Literature DB >> 25510234

Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed.

Nadja Schubert1, Jan Dudeck, Peng Liu, Anna Karutz, Stephan Speier, Marcus Maurer, Jan Tuckermann, Anne Dudeck.   

Abstract

OBJECTIVE: The function of mast cells (MCs) in autoimmune disorders has been a subject of controversy recently. MC-deficient Kit(W/W-v) mice were found to be resistant to K/BxN serum-transfer arthritis, whereas Kit(W-sh/W-sh) mice and a genetic model of MC deficiency independent of the Kit mutation were found to be fully susceptible. This debate might lead to the assumption that MCs are dispensable in autoimmunity in general. Thus, the purpose of this study was to examine the relevance of MCs to arthritis using a genetic model of inducible MC deficiency without compromised Kit signaling.
METHODS: We compared MC functions in K/BxN serum-induced arthritis and in collagen-induced arthritis (CIA) in a mouse model of inducible MC deficiency by analyzing joint inflammation, parameters of cartilage degradation and bone erosion, and the autoreactive adaptive immune response.
RESULTS: We observed a redundant role of MCs in K/BxN serum-induced arthritis, where joint inflammation is triggered by cartilage-bound immune complexes independently of T cells. In contrast, we found MCs to be critically relevant in CIA, which is provoked by two arms of autoimmune attack: autoreactive antibodies and effector T cells. In addition to diminished joint inflammation in the absence of MCs, we found a dramatic loss of T cell expansion upon immunization, accompanied by reduced T cell cytokine responses.
CONCLUSION: In this analysis of an arthritis model in which the cellular arm of adaptive immunity was not bypassed, we identified MCs as important promoters of T cell-conditioned autoimmune disorders and, consequently, as potential therapeutic targets in rheumatoid arthritis.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25510234     DOI: 10.1002/art.38996

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  27 in total

Review 1.  [Mutual influence of immune system and bones].

Authors:  T Kamradt; M Amling; B Dankbar; A Dudeck; M Gunzer; A Ignatius; G Krönke; K Kubatzky; T Pap; I Prinz; G Schett; T Schinke; J Tuckermann; A Waisman
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

Review 2.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

3.  Megakaryocytes compensate for Kit insufficiency in murine arthritis.

Authors:  Pierre Cunin; Loka R Penke; Jonathan N Thon; Paul A Monach; Tatiana Jones; Margaret H Chang; Mary M Chen; Imene Melki; Steve Lacroix; Yoichiro Iwakura; Jerry Ware; Michael F Gurish; Joseph E Italiano; Eric Boilard; Peter A Nigrovic
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

4.  Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells.

Authors:  Viktor Bugajev; Ivana Halova; Lubica Draberova; Monika Bambouskova; Lucie Potuckova; Helena Draberova; Tomas Paulenda; Sergi Junyent; Petr Draber
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

5.  Associations between D3R expression in synovial mast cells and disease activity and oxidant status in patients with rheumatoid arthritis.

Authors:  Li Xue; Xueyi Li; Qingping Chen; Juntao He; Yanying Dong; Jing Wang; Siyao Shen; Rui Jia; Quan Jin Zang; Ting Zhang; Ming Li; Yan Geng
Journal:  Clin Rheumatol       Date:  2018-06-22       Impact factor: 2.980

6.  Inhibition of inflammatory arthritis using fullerene nanomaterials.

Authors:  Anthony L Dellinger; Pierre Cunin; David Lee; Andrew L Kung; D Bradford Brooks; Zhiguo Zhou; Peter A Nigrovic; Christopher L Kepley
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 7.  Mast Cells as Regulators of T Cell Responses.

Authors:  Silvia Bulfone-Paus; Rajia Bahri
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

8.  Activated mast cells promote differentiation of B cells into effector cells.

Authors:  Anna-Karin E Palm; Gianni Garcia-Faroldi; Marcus Lundberg; Gunnar Pejler; Sandra Kleinau
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

9.  Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile.

Authors:  Daniël van der Velden; H Maxime Lagraauw; Anouk Wezel; Pierre Launay; Johan Kuiper; Tom W J Huizinga; René E M Toes; Ilze Bot; Jeroen N Stoop
Journal:  Arthritis Res Ther       Date:  2016-06-13       Impact factor: 5.156

10.  The role of Sp140 revealed in IgE and mast cell responses in Collaborative Cross mice.

Authors:  Kazufumi Matsushita; Xin Li; Yuki Nakamura; Danyue Dong; Kaori Mukai; Mindy Tsai; Stephen B Montgomery; Stephen J Galli
Journal:  JCI Insight       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.